Selegiline Transdermal System Articles
B-MS announces cost-cutting plans
19 December 2005
B-MS and Somerset in Emsam distribution deal
10 January 2005
Showing 1-4 of 4 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
